Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 146

1.

Sexually dimorphic structural abnormalities in major connections of the medial forebrain bundle in alcoholism.

Rivas-Grajales AM, Sawyer KS, Karmacharya S, Papadimitriou G, Camprodon JA, Harris GJ, Kubicki M, Oscar-Berman M, Makris N.

Neuroimage Clin. 2018 Mar 22;19:98-105. doi: 10.1016/j.nicl.2018.03.025. eCollection 2018.

2.

Cerebral white matter sex dimorphism in alcoholism: a diffusion tensor imaging study.

Sawyer KS, Maleki N, Papadimitriou G, Makris N, Oscar-Berman M, Harris GJ.

Neuropsychopharmacology. 2018 Aug;43(9):1876-1883. doi: 10.1038/s41386-018-0089-6. Epub 2018 May 9.

PMID:
29795404
3.

A Systematic, Intensive Statistical Investigation of Data from the Comprehensive Analysis of Reported Drugs (CARD) for Compliance and Illicit Opioid Abstinence in Substance Addiction Treatment with Buprenorphine/naloxone.

Blum K, Han D, Modestino EJ, Saunders S, Roy AK 3rd, Jacobs W, Inaba DS, Baron D, Oscar-Berman M, Hauser M, Badgaiyan RD, Smith DE, Femino J, Gold MS.

Subst Use Misuse. 2018 Jan 28;53(2):220-229. doi: 10.1080/10826084.2017.1400064. Epub 2017 Dec 19.

PMID:
29257919
4.

The effects of residential dual diagnosis treatment on alcohol abuse.

Schoenthaler SJ, Blum K, Fried L, Oscar-Berman M, Giordano J, Modestino EJ, Badgaiyan R.

J Syst Integr Neurosci. 2017 Jul;3(4). doi: 10.15761/JSIN.1000169. Epub 2017 Jul 17.

5.

Associations Between Personality and Drinking Motives Among Abstinent Adult Alcoholic Men and Women.

Mosher Ruiz S, Oscar-Berman M, Kemppainen MI, Valmas MM, Sawyer KS.

Alcohol Alcohol. 2017 Jul 1;52(4):496-505. doi: 10.1093/alcalc/agx016.

PMID:
28379312
6.

Gender dimorphism of brain reward system volumes in alcoholism.

Sawyer KS, Oscar-Berman M, Barthelemy OJ, Papadimitriou GM, Harris GJ, Makris N.

Psychiatry Res Neuroimaging. 2017 May 30;263:15-25. doi: 10.1016/j.pscychresns.2017.03.001. Epub 2017 Mar 6.

7.

Alcoholism and sexual dimorphism in the middle longitudinal fascicle: a pilot study.

Seitz J, Sawyer KS, Papadimitriou G, Oscar-Berman M, Ng I, Kubicki A, Mouradian P, Ruiz SM, Kubicki M, Harris GJ, Makris N.

Brain Imaging Behav. 2017 Aug;11(4):1006-1017. doi: 10.1007/s11682-016-9579-5.

8.

Hypothesizing Music Intervention Enhances Brain Functional Connectivity Involving Dopaminergic Recruitment: Common Neuro-correlates to Abusable Drugs.

Blum K, Simpatico T, Febo M, Rodriquez C, Dushaj K, Li M, Braverman ER, Demetrovics Z, Oscar-Berman M, Badgaiyan RD.

Mol Neurobiol. 2017 Jul;54(5):3753-3758. doi: 10.1007/s12035-016-9934-y. Epub 2016 May 31.

9.

Common Neurogenetic Diagnosis and Meso-Limbic Manipulation of Hypodopaminergic Function in Reward Deficiency Syndrome (RDS): Changing the Recovery Landscape.

Blum K, Febo M, Badgaiyan RD, Demetrovics Z, Simpatico T, Fahlke C, M OB, Li M, Dushaj K, Gold MS.

Curr Neuropharmacol. 2017;15(1):184-194. Review.

10.

Associations Between Cerebellar Subregional Morphometry and Alcoholism History in Men and Women.

Sawyer KS, Oscar-Berman M, Mosher Ruiz S, Gálvez DA, Makris N, Harris GJ, Valera EM.

Alcohol Clin Exp Res. 2016 Jun;40(6):1262-72. doi: 10.1111/acer.13074. Epub 2016 Apr 30.

11.

The Molecular Neurobiology of Twelve Steps Program & Fellowship: Connecting the Dots for Recovery.

Blum K, Thompson B, Demotrovics Z, Femino J, Giordano J, Oscar-Berman M, Teitelbaum S, Smith DE, Roy AK, Agan G, Fratantonio J, Badgaiyan RD, Gold MS.

J Reward Defic Syndr. 2015;1(1):46-64.

13.

Reward Deficiency Syndrome: Attentional/Arousal Subtypes, Limitations of Current Diagnostic Nosology, and Future Research.

Modestino EJ, Blum K, Oscar-Berman M, Gold MS, Duane DD, Sultan SGS, Auerbach SH.

J Reward Defic Syndr. 2015;1(1):6-9. doi: 10.17756/jrds.2015-002. Epub 2015 Feb 6.

14.

Putative dopamine agonist (KB220Z) attenuates lucid nightmares in PTSD patients: role of enhanced brain reward functional connectivity and homeostasis redeeming joy.

McLaughlin T, Blum K, Oscar-Berman M, Febo M, Agan G, Fratantonio JL, Simpatico T, Gold MS.

J Behav Addict. 2015 Jun;4(2):106-15. doi: 10.1556/2006.4.2015.008.

15.

Using the Neuroadaptagen KB200z™ to Ameliorate Terrifying, Lucid Nightmares in RDS Patients: the Role of Enhanced, Brain-Reward, Functional Connectivity and Dopaminergic Homeostasis.

McLaughlin T, Blum K, Oscar-Berman M, Febo M, Demetrovics Z, Agan G, Fratantonio J, Gold MS.

J Reward Defic Syndr. 2015;1(1):24-35.

16.

NIDA-Drug Addiction Treatment Outcome Study (DATOS) Relapse as a Function of Spirituality/Religiosity.

Schoenthaler SJ, Blum K, Braverman ER, Giordano J, Thompson B, Oscar-Berman M, Badgaiyan RD, Madigan MA, Dushaj K, Li M, Demotrovics Z, Waite RL, Gold MS.

J Reward Defic Syndr. 2015;1(1):36-45.

17.

Measures of skin conductance and heart rate in alcoholic men and women during memory performance.

Sawyer KS, Poey A, Ruiz SM, Marinkovic K, Oscar-Berman M.

PeerJ. 2015 May 5;3:e941. doi: 10.7717/peerj.941. eCollection 2015.

18.

Neurogenetics and gene therapy for reward deficiency syndrome: are we going to the Promised Land?

Blum K, Thanos PK, Badgaiyan RD, Febo M, Oscar-Berman M, Fratantonio J, Demotrovics Z, Gold MS.

Expert Opin Biol Ther. 2015 Jul;15(7):973-85. doi: 10.1517/14712598.2015.1045871. Epub 2015 May 14. Review.

PMID:
25974314
19.
20.

Dopaminergic Neurogenetics of Sleep Disorders in Reward Deficiency Syndrome (RDS).

Blum K, Oscar-Berman M, Badgaiyan RD, Khurshid KA, Gold MS.

J Sleep Disord Ther. 2014 Feb 18;3(2):126.

21.

Social cognition deficits and associations with drinking history in alcoholic men and women.

Valmas MM, Mosher Ruiz S, Gansler DA, Sawyer KS, Oscar-Berman M.

Alcohol Clin Exp Res. 2014 Dec;38(12):2998-3007. doi: 10.1111/acer.12566.

22.

Dopamine in the Brain: Hypothesizing Surfeit or Deficit Links to Reward and Addiction.

Blum K, Thanos PK, Oscar-Berman M, Febo M, Baron D, Badgaiyan RD, Gardner E, Demetrovics Z, Fahlke C, Haberstick BC, Dushaj K, Gold MS.

J Reward Defic Syndr. 2015;1(3):95-104. Epub 2015 Oct 23.

23.

rsfMRI effects of KB220Z™ on neural pathways in reward circuitry of abstinent genotyped heroin addicts.

Blum K, Liu Y, Wang W, Wang Y, Zhang Y, Oscar-Berman M, Smolen A, Febo M, Han D, Simpatico T, Cronjé FJ, Demetrovics Z, Gold MS.

Postgrad Med. 2015 Mar;127(2):232-41. Epub 2014 Dec 16.

24.

Zonisamide, topiramate, and levetiracetam: efficacy and neuropsychological effects in alcohol use disorders.

Knapp CM, Ciraulo DA, Sarid-Segal O, Richardson MA, Devine E, Streeter CC, Oscar-Berman M, Surprise C, Colaneri L, Putnam M, Waters M, Richambault C.

J Clin Psychopharmacol. 2015 Feb;35(1):34-42. doi: 10.1097/JCP.0000000000000246.

25.

Preliminary Hormonal Correlations in Female Patients as a Function of Somatic and Neurological Symptom Clusters: An Exploratory Development of a Multi-Hormonal Map for Bio-Identical Replacement Therapy (MHRT).

Braverman ER, Oscar-Berman M, Kreuk F, Kerner M, Dushaj K, Li M, Stratton D, Trudesdell C, Blum K.

J Genet Syndr Gene Ther. 2013 Dec 6;4. pii: 206.

26.

Profiles of impaired, spared, and recovered neuropsychologic processes in alcoholism.

Oscar-Berman M, Valmas MM, Sawyer KS, Ruiz SM, Luhar RB, Gravitz ZR.

Handb Clin Neurol. 2014;125:183-210. doi: 10.1016/B978-0-444-62619-6.00012-4. Review.

27.

Menopause Analytical Hormonal Correlate Outcome Study (MAHCOS) and the association to brain electrophysiology (P300) in a clinical setting.

Braverman ER, Han D, Oscar-Berman M, Karikh T, Truesdell C, Dushaj K, Kreuk F, Li M, Stratton D, Blum K.

PLoS One. 2014 Sep 24;9(9):e105048. doi: 10.1371/journal.pone.0105048. eCollection 2014.

28.

Systematic evaluation of "compliance" to prescribed treatment medications and "abstinence" from psychoactive drug abuse in chemical dependence programs: data from the comprehensive analysis of reported drugs.

Blum K, Han D, Femino J, Smith DE, Saunders S, Simpatico T, Schoenthaler SJ, Oscar-Berman M, Gold MS.

PLoS One. 2014 Sep 23;9(9):e104275. doi: 10.1371/journal.pone.0104275. eCollection 2014.

29.

Hypothesizing Darkness Induced Alcohol Intake Linked to Dopaminergic Regulation of Brain Function.

Blum K, Oscar-Berman M, Badgaiyan R, Braverman ER, Gold MS.

Psychology (Irvine). 2014 Mar;5(4):282-288.

30.

Can Genetic Testing Coupled with Enhanced Dopaminergic Activation Reduce Recidivism Rates in the Workers Compensation Legacy Cases?

Blum K, Oscar-Berman M, Blum SH, Madigan MA, Waite RL, McLaughlin T, Barh D.

J Alcohol Drug Depend. 2014 Jul;2(3). pii: 161. Epub 2014 May 29. No abstract available.

31.

Genospirituality: Our Beliefs, Our Genomes, and Addictions.

Blum K, Thompson B, Oscar-Berman M, Giordano J, Braverman E, Femino J, Barh D, Downs W, Smpatico T, Schoenthaler S.

J Addict Res Ther. 2013 Oct 10;5(4). pii: 162.

32.

A Multi-Locus Approach to Treating Fibromyalgia by Boosting Dopaminergic Activity in the Meso-Limbic System of the Brain.

Blum K, Oscar-Berman M, Waite RL, Braverman ER, Kreuk F, Li M, Dushaj K, Madigan MA, Hauser M, Simpatico T, Barh D.

J Genet Syndr Gene Ther. 2014 Jan 27;5(1):213. No abstract available.

33.

Genetic Addiction Risk Score (GARS): molecular neurogenetic evidence for predisposition to Reward Deficiency Syndrome (RDS).

Blum K, Oscar-Berman M, Demetrovics Z, Barh D, Gold MS.

Mol Neurobiol. 2014 Dec;50(3):765-96. doi: 10.1007/s12035-014-8726-5. Epub 2014 May 31.

34.

Drug abuse relapse rates linked to level of education: can we repair hypodopaminergic-induced cognitive decline with nutrient therapy?

Blum K, Schoenthaler SJ, Oscar-Berman M, Giordano J, Madigan MA, Braverman ER, Han D.

Phys Sportsmed. 2014 May;42(2):130-45. doi: 10.3810/psm.2014.05.2065.

PMID:
24875980
35.

White Matter and Cognitive Changes in Veterans Diagnosed with Alcoholism and PTSD.

Maksimovskiy AL, McGlinchey RE, Fortier CB, Salat DH, Milberg WP, Oscar-Berman M.

J Alcohol Drug Depend. 2014 Jan 1;2(1):144.

36.

Apolipoprotein Gene Polymorphisms (APOB, APOC111, APOE) in the Development of Coronary Heart Disease in Ethnic Groups of Kazakhstan.

Berkinbayev S, Rysuly M, Mussayev A, Blum K, Baitasova N, Mussagaliyeva A, Dzhunusbekova G, Makhatov B, Mussayev A, Yeshmanova A, Lesbekova R, Marchuk Y, Azhibekova R, Oscar-Berman M, Kulmaganbetov M.

J Genet Syndr Gene Ther. 2014 Jan 24;5(2):216.

37.

Hypothesizing dopaminergic genetic antecedents in schizophrenia and substance seeking behavior.

Blum K, Oscar-Berman M, Badgaiyan RD, Palomo T, Gold MS.

Med Hypotheses. 2014 May;82(5):606-14. doi: 10.1016/j.mehy.2014.02.019. Epub 2014 Feb 26.

38.

Coupling Genetic Addiction Risk Score (GARS) with Electrotherapy: Fighting Iatrogenic Opioid Dependence.

Blum K, Oscar-Berman M, Dinubile N, Giordano J, Braverman ER, Truesdell CE, Barh D, Badgaiyan R.

J Addict Res Ther. 2013 Oct 31;4(163):1000163.

39.

Low dopamine function in attention deficit/hyperactivity disorder: should genotyping signify early diagnosis in children?

Gold MS, Blum K, Oscar-Berman M, Braverman ER.

Postgrad Med. 2014 Jan;126(1):153-77. doi: 10.3810/pgm.2014.01.2735. Review.

41.

Declinol, a Complex Containing Kudzu, Bitter Herbs (Gentian, Tangerine Peel) and Bupleurum, Significantly Reduced Alcohol Use Disorders Identification Test (AUDIT) Scores in Moderate to Heavy Drinkers: A Pilot Study.

Kushner S, Han D, Oscar-Berman M, William Downs B, Madigan MA, Giordano J, Beley T, Jones S, Barh D, Simpatico T, Dushaj K, Lohmann R, Braverman ER, Schoenthaler S, Ellison D, Blum K.

J Addict Res Ther. 2013 Jul 2;4(3). pii: 153.

42.

Withdrawal from Buprenorphine/Naloxone and Maintenance with a Natural Dopaminergic Agonist: A Cautionary Note.

Blum K, Oscar-Berman M, Femino J, Waite RL, Benya L, Giordano J, Borsten J, Downs WB, Braverman ER, Loehmann R, Dushaj K, Han D, Simpatico T, Hauser M, Barh D, McLaughlin T.

J Addict Res Ther. 2013 Apr 23;4(2). doi: 10.4172/2155-6105.1000146.

43.

Brain volumes and neuropsychological performance are related to current smoking and alcoholism history.

Luhar RB, Sawyer KS, Gravitz Z, Ruiz SM, Oscar-Berman M.

Neuropsychiatr Dis Treat. 2013;9:1767-84. doi: 10.2147/NDT.S52298. Epub 2013 Nov 12.

44.

Have We Hatched the Addiction Egg: Reward Deficiency Syndrome Solution System™

Downs B, Oscar-Berman M, Waite R, Madigan M, Giordano J, Beley T, Jones S, Simpatico T, Hauser M, Borsten J, Marcelo F, Braverman E, Lohmann R, Dushaj K, Helman M, Barh D, Schoenthaler S, Han D, Blum K.

J Genet Syndr Gene Ther. 2013 Jun 3;4(136):14318.

45.

Closing the Gender Gap: The Case for Gender-Specific Alcoholism Research.

Ruiz SM, Oscar-Berman M.

J Alcohol Drug Depend. 2013 Sep;1(6). pii: e106. Epub 2013 Aug 27.

46.

Neurogenetics and Nutrigenomics of Neuro-Nutrient Therapy for Reward Deficiency Syndrome (RDS): Clinical Ramifications as a Function of Molecular Neurobiological Mechanisms.

Blum K, Oscar-Berman M, Stuller E, Miller D, Giordano J, Morse S, McCormick L, Downs WB, Waite RL, Barh D, Neal D, Braverman ER, Lohmann R, Borsten J, Hauser M, Han D, Liu Y, Helman M, Simpatico T.

J Addict Res Ther. 2012 Nov 27;3(5):139.

47.

Long term Suboxone™ emotional reactivity as measured by automatic detection in speech.

Hill E, Han D, Dumouchel P, Dehak N, Quatieri T, Moehs C, Oscar-Berman M, Giordano J, Simpatico T, Barh D, Blum K.

PLoS One. 2013 Jul 9;8(7):e69043. doi: 10.1371/journal.pone.0069043. Print 2013. Erratum in: PLoS One. 2013;8(8):doi/10.1371/annotation/be0b3a26-c1bc-4d92-98c1-c516acc8dcf2. Barh, Debmalya [added].

48.

Pharmacotherapies for Overeating and Obesity.

Yarnell S, Oscar-Berman M, Avena N, Blum K, Gold M.

J Genet Syndr Gene Ther. 2013 Apr 1;4(3):131.

49.

Hypothesizing repetitive paraphilia behavior of a medication refractive Tourette's syndrome patient having rapid clinical attenuation with KB220Z-nutrigenomic amino-acid therapy (NAAT).

Mclaughlin T, Oscar-Berman M, Simpatico T, Giordano J, Jones S, Barh D, Downs WB, Waite RL, Madigan M, Dushaj K, Lohmann R, Braverman ER, Han D, Blum K.

J Behav Addict. 2013 Jun;2(2):117-24. doi: 10.1556/JBA.2.2013.2.8.

PMID:
26165932
50.

Supplemental Content

Loading ...
Support Center